PSAMP
STLNW

P. Schoenfeld Asset Management (PSAM)’s Starling Oncology Warrant STLNW Stock Holding History

P. Schoenfeld Asset Management (PSAM)’s Portfolio STLNW Stock Details STLNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-24,999
Closed -$43K – 376
2021
Q2 		$43K Hold
24,999
– – ﹤0.01% 348
2021
Q1 		$34K Hold
24,999
– – ﹤0.01% 340
2020
Q4 		$49K Hold
24,999
– – ﹤0.01% 163
2020
Q3 		$42K Buy
+24,999
New +$41K ﹤0.01% 118

Other funds holding STLNW

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
USPCM
Union Square Park Capital Management New York $278M AUM 50.01% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

P. Schoenfeld Asset Management (PSAM)'s STLNW Position: Q3 2021 in Review

P. Schoenfeld Asset Management (PSAM) sold out of Starling Oncology Warrant (STLNW) in Q3 2021, closing a stake of 24,999 shares — an estimated $43K sold.

P. Schoenfeld Asset Management (PSAM) first reported a position in STLNW in Q3 2020 and held it in 4 quarters. The position peaked at $49K in Q4 2020. 21 funds tracked by Wall St. Rank hold STLNW as of Q3 2021.

  • P. Schoenfeld Asset Management (PSAM) reported no remaining Starling Oncology Warrant position as of Q3 2021 after selling out during the quarter.
  • P. Schoenfeld Asset Management (PSAM) sold 24,999 Starling Oncology Warrant shares in Q3 2021, an estimated $43K.
  • P. Schoenfeld Asset Management (PSAM) first reported a position in Starling Oncology Warrant in Q3 2020 and held it in 4 quarters.
  • P. Schoenfeld Asset Management (PSAM)'s Starling Oncology Warrant position peaked at $49K in Q4 2020.
  • 21 funds tracked by Wall St. Rank held Starling Oncology Warrant as of Q3 2021.

Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q3 2021, filed 15 Nov 2021.